Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Fasenra (benralizumab) for the Treatment of Asthma

Drug (Brand / Generic)

Fasenra / benralizumab

Developer

AstraZeneca

Therapy Class

Monoclonal antibody

Current Indication

Asthma

Market Sector

Respiratory

Development Status

Approved in the US, MAA under review in Europe
Expand

Go Top